Advertisement
Home Tags Food & Drug Administration

Tag: Food & Drug Administration

The drug Rubraca (rucaparib) has been granted accelerated approval by the U.S. Food and Drug Administration to treat advanced ovarian cancer.

FDA Grants Fast-Track Approval to Ovarian Cancer Drug

Rubraca's use is specific to women with deleterious BRCA mutations
Maci (autologous cultured chondrocytes on porcine collagen membrane) has been approved by the U.S. Food and Drug Administration to repair symptomatic

FDA OKs Autologous Cellularized Scaffold for Knee Cartilage Repair

For symptomatic, full-thickness cartilage defects of the knee in adult patients
Intrarosa (prasterone) has been approved by the U.S. Food and Drug Administration to treat women who have moderate-to-severe pain during sexual intercourse caused by postmenopausal vulvar and vaginal atrophy.

FDA Approves Intrarosa for Postmenopausal Pain During Sex

Drug contained in a once-daily vaginal insert
The Amplatzer PFO Occluder device has been approved by the U.S. Food and Drug Administration to prevent another stroke among patients who have had at least one prior stroke involving a patent foramen ovale.

FDA Approves Device to Prevent Recurrent Strokes in PFO Patients

For patients who had prior stroke related to patent foramen ovale
Supplemental testosterone and related anabolic-androgenic steroids can cause heart attacks

FDA Warns of Testosterone, AAS Abuse and Dependence

Many American men take them, but heart and psychological issues can occur, agency says
Lartruvo (olaratumab) has been approved by the U.S. Food and Drug Administration to treat adults with certain soft tissue sarcomas.

FDA Approves New Treatment for Advanced Soft Tissue Sarcoma

Sanctioned for use with doxorubicin in cases that cannot be treated with radiation or surgery
The first automated insulin delivery device for type 1 diabetes has been approved by the U.S. Food and Drug Administration for patients aged 14 and older.

FDA Approves ‘Artificial Pancreas’ for Type 1 Diabetes

MiniMed 670G hybrid closed loop system automatically monitors glucose, delivers insulin
Exondys 51 (eteplirsen) injection has been approved by the U.S. Food and Drug Administration for certain patients with Duchenne muscular dystrophy. It is the first drug to gain FDA approval for the condition.

FDA Approves First Drug for Duchenne Muscular Dystrophy

Exondys 51 sanctioned for patients with mutation of the dystrophin gene amenable to exon 51 skipping
A device that uses a small balloon to treat Eustachian tube dysfunction has been approved by the U.S. Food and Drug Administration.

FDA Approves Balloon Device for Eustachian Tube Dysfunction

Designed to relieve pressure, pain, or clogged or muffled sensations occuring in the ear
A new biological drug to treat rheumatoid arthritis and other inflammatory diseases has been approved by the U.S. Food and Drug Administration.

FDA Approves Biosimilar Drug Erelzi for Rheumatoid Arthritis

Erelzi is a biosimilar for Enbrel; treats RA and other inflammatory diseases